RC
Robert Charles Jahr bought OTLK stock
Robert Charles Jahr, Chief Executive Officer of Outlook Therapeutics, Inc. (OTLK), bought 151,515 shares of OTLK stock, per an SEC Form 4 filed Aug 15, 2026.
The shares came through a private deal, not the open market.
The trade happened on Aug 14, 2026, 1 day before it was made public.
OTLK has moved -45.4% since the trade date, from $0.76 to $0.41 (Nov 13, 2026 close).
- Traded
- Aug 14, 2026
- Disclosed
- Aug 15, 2026
- Filing delay
- 1 day
- Price since
- -45.4%
- Role
- Chief Executive Officer
- Source
- SEC Form 4